Optimizing adherence and persistence to non-vitamin K antagonist oral anticoagulant therapy in atrial fibrillation

Atrial fibrillation (AF) is associated with an increased risk of stroke, which can be prevented by the use of oral anticoagulation. Although non-vitamin K antagonist oral anticoagulants (NOACs) have become the first choice for stroke prevention in the majority of patients with non-valvular AF, adher...

Descripción completa

Detalles Bibliográficos
Autores principales: Farinha, José Maria, Jones, Ian D, Lip, Gregory Y H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Supplement Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850710/
https://www.ncbi.nlm.nih.gov/pubmed/35185408
http://dx.doi.org/10.1093/eurheartj/suab152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850710/
https://www.ncbi.nlm.nih.gov/pubmed/35185408
http://dx.doi.org/10.1093/eurheartj/suab152

Ejemplares similares